Sciensus will be attending the upcoming ASCO (American Society of Clinical Oncology).
ASCO is one of the most influential events in oncology, bringing together global leaders in cancer research, clinical practice, and patient care to advance the future of oncology treatment.
Join us in Chicago to discover your trusted European end-to-end partner for oncology and specialty medicines.
Accelerate access. Extend adherence. Deliver value.
Getting patients on treatment fast – and keeping them on it – is one of the greatest clinical and commercial challenges in oncology treatment.
Whether you’re launching a new therapy, scaling market access across Europe, or supporting real-world evidence generation, Sciensus delivers the infrastructure and expertise to help you reach patients where they are – and keep them supported and compliant.
Leveraging over 30 years of clinical experience, deep therapeutic expertise, and personalised digital innovation, we help biopharma and healthcare systems bring oncology treatments to patients.
What we deliver for oncology partners
Decentralised clinical trial support
Accelerate access to therapy through decentralised trials and recruitment support across EU markets.
Expanded access program
Our partners benefit from our regulatory, marketing and commercial strategy expertise, ensuring a faster and easier route to market.
Wholesale and distribution
Secure, specialist delivery across Europe – to hospitals, pharmacies, and directly to patients.
Real-world data
Real-world insights from millions of patient touchpoints, supporting outcomes reporting, HTA submissions, and PSP optimisation.
Patient support programs
Tech-enabled, nurse-supported programs tailored for oncology – from onboarding to long-term engagement.
About Sciensus
Sciensus is a proven life sciences solutions partner with more than 30 years’ experience in navigating and unlocking the complex European healthcare ecosystem to maximise patient reach. We help accelerate the development journey, bringing medicines into the market and directly to patients to improve health outcomes. Through cutting-edge patient engagement programmes, offering an exclusive combination of skilled in-person care and digital support, we help patients make the most of their treatment and generate real-world evidence that can be used to improve treatment pathways.